Last reviewed · How we verify
Formulation N3
At a glance
| Generic name | Formulation N3 |
|---|---|
| Also known as | JNJ-53718678 |
| Sponsor | Janssen Sciences Ireland UC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Formulation N3 CI brief — competitive landscape report
- Formulation N3 updates RSS · CI watch RSS
- Janssen Sciences Ireland UC portfolio CI